`Approvedfor use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995 no personsare required to respondto a collection of information unlessit displays a valid OMB control number.
`
`UTILITY
`
`PATENT APPLICATION
`rile|NONAQUEOUS ELECTROLYTE SECONDARY
`TRANSMITTAL
`BATTERY AND SECONDARY BATTERY MODULE
`a(Only for new nonprovisional applications under 37 CFR 1.53(b))
`Commissioner for Patents
`APPLICATION ELEMENTS
`ADDRESSTO:
`P.O. Box 1450
`See MPEPchapter 600 concerning utility patent application contents.
`:
`Alexandria, VA 22313-1450
`
`Label No.
`
`Fee Transmittal Form
`(PTO/SB/17 or equivalent)
`Applicant asserts small entity status.
`See 37 CFR 1.27
`
`Applicant certifies micro entity status. See 37 CFR 1.29.
`Applicant must attach form PTO/SB/15A orB or equivalent.
`39
`Specification
`[Total Pages
`Both the claims and abstract must start on a new page.
`(See MPEP § 608.01(a) for information on the preferred arrangement)
`
`ACCOM PANYING APPLICATION PAPERS
`10. [| Assignment Papers
`(cover sheet & document(s))
`
`
`
`
`Nameof Assignee
`.
`.
`Panason Ic Corporation
`Kadoma-shi, Japan
`
`
`Toyota-shi, Japan
`
`x|Drawing(s) (35 U.S.C. 113) [Total Sheets 8 TOYOTA JIDOSHA KABUSHIKI KAISHA
`
`
`
`11.
`37 CFR3.73(c) Statement
`Powerof Attorney
`6
`[Total Pages
`. Inventor’s Oath or Declaration
`(when there is an assignee)
`—_
`(including substitute statements under 37 CFR 1.64 and assignments
`12. [| English Translation Document(ifapplicable)
`serving as an oath ordeclaration under 37 CFR 1.63(e))
`13. x|Information Disclosure Statement
`a.
`Newly executed (original or copy)
`(PTO/SB/08 or PTO-1449)
`
`b.[| A copyfrom a prior application (37 CFR 1.63(d)) Copiesof citations attached
`. 14.[| Preliminary AmendmentApplication Data Sheet * See note below.
`
`
`
`See 37 CFR 1.76 (PTO/AIA/14 or equivalent)
`
`Return Receipt Postcard
`(MPEP § 503) (Should be specifically itemized)
`
`CD-ROM or CD-R
`in duplicate, large table, or Computer Program (Appendix)
`
`Landscape Table on CD
`Certified Copy of Priority Document(s)
`Nucleotide and/or Amino Acid Sequence Submission
`(if foreign priority is claimed)
`(if applicable, items a. — c. are required)
`Nonpublication Request
`a.
`Computer Readable Form (CRF)
`Under 35 U.S.C. 122(b)(2)(B)(i). Applicant must attach form PTO/SB/35
`or equivalent.
`b.
`Specification Sequence Listing on:
`i.[ _] CD-ROMor CD-R @copies); or 18.[|Other:
`
`ii. [| Paper
`Statements verifying identity of above copies
`
`56,171
`
`
`
`—
`
`15.
`
`16.
`
`17.
`
`
`
`*Note:
`
`(1) Benefit claims under 37 CFR 1.78 and foreign priority claims under 1.55 must be included in an Application Data Sheet (ADS).
`(2) For applicationsfiled under 35 U.S.C. 111, the application must contain an ADS specifying the applicantif the applicant is an
`assignee, person to whom theinventoris under an obligation to assign, or person who otherwise showssufficient proprietary
`interest in the matter. See 37 CFR 1.46(b).
`
`19. CORRESPONDENCE ADDRESS
`The address associated with Customer Number:
`38834
`OR
`|_| Correspondenceaddress below
`re
`esp
`LBOT
`Feouty||teepnone]|ema
`/Michael J. Caridi/
`March 12, 2021
`
`Michael J. Caridi
`
`